Last updated on February 2018

Effect of Ejiao Compound in the Treatment of Postpartum Anemia of Qi-blood Deficiency Syndrome


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Postpartum Anemia
  • Age: Between 18 - 45 Years
  • Gender: Female

Inclusion Criteria:

  1. Women aged 18 years to 45 years with mild postpartum anemia (Hb <10 g/dl and 7 g/dl at 24-48 hours postpartum);
  2. Absence of antepartum anemia, which is defined as Hb11.0 g/dL within 48 hours before delivery;
  3. Singleton pregnancy;
  4. Type of syndrome in Traditional Chinese Medicine is "Qi-blood deficiency".
  5. Patients having not received blood transfusion or any forms of anti-anemia treatment in Western medicine or TCM in the last 12 weeks;
  6. Informed consent obtained.

Exclusion Criteria:

  1. Type of syndrome in TCM is NOT "Qi-blood deficiency";
  2. Antepartum anemia;
  3. Twin or multiple pregnancies;
  4. A history of haematological disease (e.g. sickle cell anemia or thalassemias);
  5. A history of undigestive disease (e.g. gastric ulcer, gastritis) or inflammatory bowel disease;
  6. A history of cardiovascular diseases, renal or liver disease, asthma, thromboembolism, HIV infection, tuberculosis, cancer and seizures;
  7. Patients having received blood transfusion or any forms of anti-anemia treatment in Western medicine or TCM in the last 12 weeks;
  8. Alcohol or drug abuse;
  9. Patients with mental illness or poor compliance to medical treatment;
  10. Participation in another clinical trial within the previous three months;
  11. No informed consent obtained.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.